EVSRX
Price
$25.74
Change
-$0.17 (-0.66%)
Updated
Nov 14 closing price
VSTSX
Price
$281.89
Change
-$1.93 (-0.68%)
Updated
Nov 14 closing price
Ad is loading...

EVSRX vs VSTSX

Header iconEVSRX vs VSTSX Comparison
Open Charts EVSRX vs VSTSXBanner chart's image
Allspring Disciplined US Core R6
Price$25.74
Change-$0.17 (-0.66%)
VolumeN/A
CapitalizationN/A
Vanguard Total Stock Mkt Idx Instl Sel
Price$281.89
Change-$1.93 (-0.68%)
VolumeN/A
CapitalizationN/A
EVSRX vs VSTSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
EVSRX vs. VSTSX commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EVSRX is a Buy and VSTSX is a Buy.

FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 1.73T vs. EVSRX (1.2B). VSTSX pays higher dividends than EVSRX: VSTSX (1.36) vs EVSRX (0.96). EVSRX was incepted earlier than VSTSX: EVSRX (9 years) vs VSTSX (8 years). EVSRX is a more actively managed with annual turnover of: 43.00 vs. VSTSX (2.00). EVSRX has a lower initial minimum investment than VSTSX: EVSRX (0) vs VSTSX (5000000000). VSTSX annual gain was more profitable for investors over the last year : 33.42 vs. EVSRX (28.11). VSTSX return over 5 years is better than : 87.54 vs. EVSRX (44.81).
EVSRXVSTSXEVSRX / VSTSX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years8 years-
Gain YTD31.32324.912126%
Front LoadN/AN/A-
Min. Initial Investment05000000000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.2B1.73T0%
Annual Yield % from dividends0.961.3670%
Returns for 1 year28.1133.4284%
Returns for 3 years4.9422.8822%
Returns for 5 years44.8187.5451%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GMRE8.890.10
+1.14%
Global Medical REIT
TRX0.37N/A
+0.99%
TRX Gold Corp
NIO4.610.03
+0.66%
NIO Inc.
FA18.02-0.56
-3.01%
First Advantage Corp
NBY0.71-0.07
-8.67%
NovaBay Pharmaceuticals